Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr₹2,588 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,209 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹4,209 Cr
Mar2024₹3,743 Cr
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr
Mar2021₹2,588 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2025 ₹4,209 Cr
12.45
Mar2024 ₹3,743 Cr
12.02
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr
11.66
Mar2021 ₹2,588 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹37,190.2 Cr 1.3% 1.6% 13.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -1.2% -2.3% 5.3% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr -1% -0.9% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr -1.3% 1.4% 38.1% Stock Analytics
CIPLA ₹113,155.0 Cr -0.1% 4.8% -6.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -2.8% -0.3% 1.2% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

1.3%

1.6%

13.8%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses